Coral Laboratories Limited (BOM:524506)

Market Cap	2.64B
Revenue (ttm)	1.16B
Net Income (ttm)	271.16M
Shares Out	3.57M
EPS (ttm)	75.89
PE Ratio	9.74
Forward PE	n/a
Dividend	2.00 (0.27%)
Ex-Dividend Date	n/a

Volume	1,429
Average Volume	973
Open	730.00
Previous Close	716.85
Day's Range	721.05 - 743.80
52-Week Range	370.95 - 999.00
Beta	0.79
RSI	60.59
Earnings Date	May 23, 2025

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant products, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic products, antimalarial drugs, antipsychotic drugs, thyroid, and kits, oral antise...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 142
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524506

Financial Performance

In 2023, Coral Laboratories's revenue was 836.60 million, an increase of 7.09% compared to the previous year's 781.19 million. Earnings were 157.89 million, an increase of 144.97%.